Safety profiles of biosimilars vs. their EU reference products: INNs (adalimumab, bevacizumab, trastuzumab, rituximab, infliximab, etanercept).
Saved in:
| Title: | Safety profiles of biosimilars vs. their EU reference products: INNs (adalimumab, bevacizumab, trastuzumab, rituximab, infliximab, etanercept). |
|---|---|
| Authors: | Kopanarov, Valentin1 (AUTHOR), Benisheva, Tatyana1 (AUTHOR) benicheva_tb@yahoo.com, Naydenova, Radoslava1 (AUTHOR), Gergova, Veska1 (AUTHOR), Dimitrov, Dimitar1 (AUTHOR), Sidjimova, Dobriana1 (AUTHOR), Mateev, Hristo1 (AUTHOR) |
| Source: | Biotechnology & Biotechnological Equipment. Dec2025, Vol. 39 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
